youtube_live
Q3 2026 earnings • released • EPS beat +2,32% • Revenue miss -0,16%
See resultschevron_right
ALC:NYSE
Alcon
71,83 $
arrow_downward
-0,86%(-0,62) 1D
72,50 $
arrow_upward
+0,93% (+0,67)todayPre-market
Closed: 12 նոյ, 16:00:04 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
73,06 $
High
73,96 $
Low
71,64 $
Mkt. cap
30,58 մլրդ
Avg. vol.
2,08 մլն
Volume
1,42 հզր
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 մլն
No. of employees
25 հզր
Open
73,06 $
High
73,96 $
Low
71,64 $
Mkt. cap
30,58 մլրդ
Avg. vol.
2,08 մլն
Volume
1,42 հզր
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 մլն
No. of employees
25 հզր
News stories
From web sources and news partners
agefi.com
·
12 ժամ առաջ
Alcon’s share price slump fails to deter analysts
Investing.com
·
16 ժամ առաջ
Stifel cuts Alcon stock price target on 2027 growth concerns
Yahoo Finance
·
18 ժամ առաջ
Alcon (SWX:ALC) Stock Could Be 47% Undervalued After Neurotech Acquisition
Benzinga
·
22 ժամ առաջ
NVIDIA To $186? Here Are 10 Top Analyst Forecasts For Thursday
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon
CEODavid J. Endicott
Employees25 հզր
Founded1945
HeadquartersԺնև, Ժնև, Շվեյցարիա
SectorHealth Care
Industry-
Websitealcon.com